Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
• 1.4 Market by Type
  • 1.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CINV
  • 1.4.3 PONV
• 1.5 Market by Application
  • 1.5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Ambulatory Surgical Centers
  • 1.5.4 Diagnostic Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2015-2026)
• 2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Regions
  • 2.2.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Chemotherapy-Induced Nausea and Vomiting (CINV) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Market Size
  • 3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2015-2020)
  • 3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
  • 3.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2019
• 3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
• 3.4 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
• 3.5 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2015-2020)
• 4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
• 5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 6.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in North America (2019-2020)
• 6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 7.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Europe (2019-2020)
• 7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

8 China

• 8.1 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 8.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in China (2019-2020)
• 8.3 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 8.4 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 9.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Japan (2019-2020)
• 9.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 9.4 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 10.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

11 India

• 11.1 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in India (2019-2020)
• 11.3 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 11.4 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
• 12.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
• 12.4 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Merck
  • 13.1.1 Merck Company Details
  • 13.1.2 Merck Business Overview
  • 13.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020))
  • 13.1.5 Merck Recent Development
• 13.2 Eisai
  • 13.2.1 Eisai Company Details
  • 13.2.2 Eisai Business Overview
  • 13.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.2.5 Eisai Recent Development
• 13.3 ProStrakan
  • 13.3.1 ProStrakan Company Details
  • 13.3.2 ProStrakan Business Overview
  • 13.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.3.5 ProStrakan Recent Development
• 13.4 Helsinn Holding
  • 13.4.1 Helsinn Holding Company Details
  • 13.4.2 Helsinn Holding Business Overview
  • 13.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.4.5 Helsinn Holding Recent Development
• 13.5 Mundipharma
  • 13.5.1 Mundipharma Company Details
  • 13.5.2 Mundipharma Business Overview
  • 13.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.5.5 Mundipharma Recent Development
• 13.6 Qilu Pharma
  • 13.6.1 Qilu Pharma Company Details
  • 13.6.2 Qilu Pharma Business Overview
  • 13.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.6.5 Qilu Pharma Recent Development
• 13.7 Teva
  • 13.7.1 Teva Company Details
  • 13.7.2 Teva Business Overview
  • 13.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.7.5 Teva Recent Development
• 13.8 Novartis
  • 13.8.1 Novartis Company Details
  • 13.8.2 Novartis Business Overview
  • 13.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.8.5 Novartis Recent Development
• 13.9 Heron Therapeutics
  • 13.9.1 Heron Therapeutics Company Details
  • 13.9.2 Heron Therapeutics Business Overview
  • 13.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.9.5 Heron Therapeutics Recent Development
• 13.10 Roche
  • 13.10.1 Roche Company Details
  • 13.10.2 Roche Business Overview
  • 13.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 13.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 13.10.5 Roche Recent Development
• 13.11 Mylan
  • 10.11.1 Mylan Company Details
  • 10.11.2 Mylan Business Overview
  • 10.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 10.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 10.11.5 Mylan Recent Development
• 13.12 Tesaro
  • 10.12.1 Tesaro Company Details
  • 10.12.2 Tesaro Business Overview
  • 10.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
  • 10.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
  • 10.12.5 Tesaro Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer